Effects of six functional SNPs on the urinary 8-isoprostane level in a general Japanese population; Shimane COHRE Study

Disease Markers

Volumn 30, Issue 6, 2011, Pages 291-298

  Suyama, Yoji ^a   Matsuda, Chikashi ^a   Isomura, Minoru ^b   Hamano, Tsuyoshi ^a   Karino, Kenji ^a   Yamasaki, Masayuki ^a   Yamaguchi, Shuhei ^a   Shiwaku, Kuninori ^a   Masuda, Junichi ^a   Nabika, Toru ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

8 isoprostane; generalized multiple dimensionality reduction; Oxidative stress; SNPs

Indexed keywords

8 ISOPROSTANE; CYTOSINE; THYMINE;

AGED; ARTICLE; CONFOUNDING VARIABLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; JAPANESE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; URINE LEVEL;

EID: 79960739144     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0787     Document Type: Article

References (35)

1. D.D. Heistad, Oxidative stress and vascular diseases, Arte-rioscler Thromb Vasc Biol 26 (2006), 689-695.
2. M.C. Houston, The role of cellular micronutrient analysis, nu-traceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease, Ther Adv Cardiovasc Dis 4 (2010), 165-183.
3. A.L. Levonen, E. Vähäkangas, J.K. Koponen and S. Ylä-Herttuala, Antioxidant gene therapy for cardiovascular disease: current status and future perspectives, Circulation 117 (2008), 2142-2150. (Pubitemid 351572172)
4. J.W. Stephens, S.C. Bain and S.E. Humphries, Gene-environment interaction and oxidative stress in cardiovascular disease, Atherosclerosis 200 (2008), 229-238.
5. V.H. Brophy, R.L. Jampsa, J.B. Clendenning, L.A. McKinstry, G.P. Jarvik and C.E. Furlong, Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression, Am J Hum Genet 68 (2001), 1428-1436. (Pubitemid 32510618)
6. M. Nakayama, H. Yasue, M. Yoshimura, Y. Shimasaki, K. Kugiyama, H. Ogawa, T. Motoyama, Y. Saito, Y. Ogawa, Y. Miyamoto and K. Nakao, T-786->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm, Circulation 99 (1999), 2864-2870. (Pubitemid 29258973)
7. D.M. Stafforini, K. Satoh, D.L. Atkinson, L.W. Tjoelker, C. Eberhardt, H. Yoshida, T. Imaizumi, S. Takamatsu, G.A. Zimmerman, T.M. McIntyre, P.W. Gray and S.M. Prescott, Platelet-activating factor acetylhydrolase deficiency, A mis-sense mutation near the active site of an anti-inflammatory phospholipase, J Clin Invest 97 (1996), 2784-2791. (Pubitemid 26197091)
8. T.J. Guzik, N.E. West, E. Black, D.McDonald, C. Ratnatunga, R. Pillai and K.M. Channon, Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis, Circulation 102 (2000), 1744-1747.
9. C. Cahilly, C.M. Ballantyne, D.S. Lim, A. Gotto and A.J. Marian, A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis, Circ Res 86 (2000), 391-395.
10. L. Brattström, D.E. Wilcken, J.Ohrvik and L. Brudin, Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis, Circulation 98 (1998), 2520-2526. (Pubitemid 29001189)
11. J.D. Morrow, Y. Chen, C.J. Brame, J. Yang, S.C. Sanchez, J. Xu, W.E. Zackert, J.A. Awad and L.J. Roberts, The iso-prostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation, Drug Metab Rev 31 (1999), 117-139. (Pubitemid 29106654)
12. J. Nourooz-Zadeh, Key issues in F2-isoprostane analysis, Biochem Soc Trans 36 (2008), 1060-1065.
13. H. Shibata, T. Nabika, H. Moriyama, J. Masuda and S. Kobayashi, Correlation of NO metabolites and 8-iso-prostaglandin F2a with periventricular hyperintensity severity, Arteiroscler Thromb Vasc Biol 24 (2004), 1659-1663. (Pubitemid 39180891)
14. Y. Jang, O.Y. Kim, S.J. Koh, J.S. Chae, Y.G. Ko, J.Y. Kim, H. Cho, T.S. Jeong, W.S. Lee, J.M. Ordovas and J.H. Lee, The Val279Phe variant of the lipoprotein-associated phospho-lipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men, J Clin Endocrinol Metab 9 (2006), 3521-3527. (Pubitemid 44402131)
15. A. Upadhyay, M.G. Larson, C.Y. Guo, R.S. Vasan, I. Lipinska, C.J. O'Donnell, S. Kathiresan, J.B. Meigs, J.F. Keaney J. Jr, Rong, E.J. Benjamin and C.S. Fox, Inflammation, kidney function and albuminuria in the Framingham Offspring cohort, Nephrol Dial Transplant 25 (2010), in press.
16. X.Y. Lou, G.B. Chen, L. Yan, J.Z. Ma, J. Zhu, R.C. Elston and M.D. Li, A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicontine dependence, Am J Hum Genet 80 (2007), 1125-1137. (Pubitemid 47579348)
17. S. Matsuo, E. Imai, M. Horio, Y. Yasuda, K. Tomita, K. Nit-ta, K. Yamagata, Y. Tomino, H. Yokoyama and A. Hishida, Collaborators developing the Japanese equation for estimated GFR, Revised equations for estimated GFR from serum creatinine in Japan, Am J Kidney Dis 53 (2009), 982-992.
18. M.D. Ritchie, L.W. Hahn, N. Roodi, L.R. Bailey, W.D. Dupont, F.F. Parl and J.H. Moore, Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer, Am J Hum Genet 69 (2001), 138-147. (Pubitemid 32614026)
19. L.W. Hahn, M.D. Ritchie and J.H. Moore, Multifactor dimensionality reduction software for detecting gene-gene and gene-environmant interactions, Bioinformatics 19 (2003), 376-382. (Pubitemid 36284937)
20. S. Nasreen, T. Nabika, H. Shibata, H. Moriyama, K. Ya-mashita, J. Masuda and S. Kobayashi, T-786C polymorphism in endothelial NO synthase gene affects cerebral circulation in smokers: possible gene-environmental interaction, Arte-rioscler Thromb Vasc Biol 22 (2002), 605-610. (Pubitemid 34408741)
21. A. Imamura, R. Takahashi, R.Murakami, H. Kataoka, X.W. Cheng, Y. Numaguchi, T. Murohara and K. Okumura, The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels, Eur J Endocrinol 158 (2008), 189-195. (Pubitemid 351298535)
22. T. Suehiro, T. Nakamura, M. Inoue, T. Shiinoki, Y. Ikeda, Y. Kumon, M. Shindo, H. Tanaka and K. Hashimoto, A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression, Atherosclerosis 150 (2000), 295-298. (Pubitemid 30336541)
23. M. Iemitsu, H. Murakami, K. Sanada, K. Yamamoto, H. Kawano, Gando and M. Miyachi, Lack of carotid stiffening associated with MTHFR 677TT genotype in cardiorespiratory fit adults, Physiol Genomics 42 (2010), 259-265.
24. B. Lassegue and K.K. Griendling, NADPH oxidases: functions and pathologies in the vasculature, Arterioscler Thromb Vasc Biol 30 (2010), 653-661.
25. A.D. Watson, J.A. Berliner, S.Y. Hama, B.N. La Du, K.F. Faull, A.M. Fogelman and M. Navab, Protective effect of high density lipoprotein associated paraoxonase: inhibitionof the biological activity of minimally oxidized low density lipopro-tein, J Clin Invest 96 (1995), 2882-2891.
26. T. Wang, K. Karino, M. Yamasaki, Y. Zhang, J. Masuda, S. Ya-maguchi, K. Shiwaku and T. Nabika, Effects of G994T in the Lp-PLA2 gene on the plasma oxidized LDL leel and carotid intima-media thickness in Japanese: The Shimane Study, Am J Hypertens 22 (2009), 742-747.
27. D. Gemmati, M. Previati, M.L. Serino, S. Moratelli, S. Guer-ra, S. Capitani, E. Forini, G. Ballerini and G.L. Scapoli, Low folate levels and thermolabile methylenetetrahydrofolate re-ductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects, Arterioscler Thromb Vasc Biol 19 (1999), 1761-1767. (Pubitemid 29323837)
28. R.H. Böger, S.M. Bode-Böger, K. Sydow, D.D. Heistad and S.R. Lentz, Plasma concentration of asymmetric dimethylargi-nine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hyper-cholesterolemia, Arterioscler Thromb Vasc Biol 20 (2000), 1557-1564. (Pubitemid 30353888)
29. C. Zoccali, ADMA: a cardiovascular and renal risk factor on the move, J Hypertens 24 (2006), 611-619.
30. D.M. Stafforini, J.R. Sheller, T.S. Blackwell, A. Sapirstein, F.E. Yull, T.M. McIntyre, J.V. Bonventre, S.M. Prescott and L.J. Roberts II, Release of gree F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases, J Biol Chem 281 (2006), 4616-4623. (Pubitemid 43847720)
31. Wellcome Trust Case Control Consortium, Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls, Nature 447 (2007), 661-678.
32. Y.S. Cho, M.J. Go, Y.J. Kim, J.Y. Heo, J.H. Oh, H.J. Ban, D. Yoon, M.H. Lee, D.J. Kim, M. Park, S.H. Cha, J.W. Kim, B.G. Han, H. Min, Y. Ahn, M.S. Park, H.R. Han, H.Y. Jang, E.Y. Cho, J.E. Lee, N.H. Cho, C. Shin, T. Park, J. W.Park, J. K.Lee, L. Cardon, G. Clarke, M.I. McCarthy, J.Y. Lee, J.K. Lee, B. Oh and H.L. Kim, A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits, Nat Genet 41 (2009), 527-534.
33. D.B. Goldstein, Common genetic variation and human traits, N Engl J Med 360 (2009), 1696-1698.
34. G. Gibson, Hints of hidden heritability in GWAS, Nat Genet 42 (2010), 558-560.
35. R.J. Neuman, J. Wasson, G. Atzmon, J. Wainstein, Y. Yerushalmi, J. Cohen, N. Barzilai, I. Blech, B. Glaser and M.A. Permutt, Gene-gene interactions lead to higher risk for development of type 2 diabetes in an Ashkenazi Jewish population, PLoS One 5 (2010), e9903.